ADC Therapeutics ADCT
NYSE ADCT
$1.43 -0.16 (-10.06%)
At close: Oct 23, 2026 · 4:00 PM EDT

ADC Therapeutics (ADCT) Return on Equity [ROE] (2021 - 2023)

Updated

ADC Therapeutics' Return on Equity [ROE] was -4155.58% in Q2 2023, down 4021.08 percentage points from -134.50% a year earlier and down 3787.44 percentage points from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Return on Equity [ROE] (2021 - 2023) Analysis & Trends

For FY2022, Return on Equity [ROE] at ADC Therapeutics came in at -133.46%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 19.33%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.21%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 31.52%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 21.39%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 83.75%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -18.38%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.97%
10 ADC Therapeutics 182.24 Mn -763.95 Mn 16.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -4,155.58%
Mar 31, 2023 -368.15%
Jun 30, 2022 -134.50%
Mar 31, 2022 -123.25%
Jun 30, 2021 -73.95%
API Access

ADC Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEY